BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 32719361)

  • 1. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
    Chang S; Sun G; Zhang D; Li Q; Qian H
    Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
    Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
    World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D; Feng M; Ma X; Tao K; Wang G
    Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
    Li Z; Yao H; Wang S; Li G; Gu X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
    Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
    Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
    Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
    Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer.
    Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH
    Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway.
    Zhang X; Yao J; Shi H; Gao B; Zhou H; Zhang Y; Zhao D; Gao S; Wang C; Zhang L
    Cell Death Dis; 2021 Aug; 12(9):802. PubMed ID: 34420031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
    Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y
    J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-141-3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer.
    Liang Z; Li X; Liu S; Li C; Wang X; Xing J
    Biochem Biophys Res Commun; 2019 Jun; 514(3):699-705. PubMed ID: 31078266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
    Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
    Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1.
    Zhang L; Dong X; Yan B; Yu W; Shan L
    Cell Death Dis; 2020 Jul; 11(7):542. PubMed ID: 32681092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG16 promotes colorectal cancer cell proliferation, migration, and epithelial-mesenchymal transition through miR-124-3p/MCP-1.
    Chen ZY; Wang XY; Yang YM; Wu MH; Yang L; Jiang DT; Cai H; Peng Y
    Gene Ther; 2022 Apr; 29(3-4):193-205. PubMed ID: 32859986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.
    Liu M; Xu A; Yuan X; Zhang Q; Fang T; Wang W; Li C
    J Transl Med; 2015 Jun; 13():195. PubMed ID: 26084278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
    Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
    Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.